AdaptHealth sees FY24 revenue $3.255B-$3.315B, consensus $3.31B

The company is updating previous financial guidance for fiscal year 2024 by adjusting the midpoint for net revenue to account for the disposition of certain non-core assets, however, the company is maintaining the midpoint for Adjusted EBITDA, and increasing the midpoint for free cash flow. Net revenue of $3.255 billion to $3.315 billion from $3.25 billion to $3.35 billion; Adjusted EBITDA of $660 million to $700 million from $650 million to $710 million; Free cash flow of $160 million to $180 million from $150 million to $180 million